Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Trichosanthes kirilowii** is a perennial flowering plant in the family Cucurbitaceae, widely used in traditional Chinese medicine (TCM) as one of the 50 fundamental herbs, particularly under the names *guālóu* (fruit) and *tiān huā fěn* (tuber). Medicinally, its root, fruit, and seeds are used for a variety of purposes, including as expectorants, antiasthmatics, anti-inflammatories, and anti-platelet agents. Biochemically, the plant contains several active components, notably trichosanthin (a type 1 ribosome-inactivating protein with antiviral—e.g., anti-HIV—effects) and cucurbitacins (with antitumor and anti-inflammatory activity). Modern studies suggest possible efficacy against respiratory disorders (cough, phlegm, asthma), cardiovascular conditions (angina, myocardial infarction), digestive disorders (gastric ulcers, Helicobacter pylori), immunomodulation, anti-inflammation, and as an adjunct in cancer therapy via inhibition of STAT3 signaling pathways. Mechanistically, it can inhibit STAT3 phosphorylation, reduce inflammatory cytokines, and induce cancer cell apoptosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on trichosanthes kirilowii.